Group One Trading’s Acurx Pharmaceuticals ACXP Stock Holding History

Group One Trading’s Portfolio ACXP Stock Details ACXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-65	Closed	-$2.47K	–	7184
2024 Q3	$2.47K	Sell	65 -190	-75%	-$8.04K	﹤0.01%	6093
2024 Q2	$11.5K	Sell	255 -145	-36%	-$6.38K	﹤0.01%	5572
2024 Q1	$19.6K	Buy	400 +340	+567%	+$22.1K	﹤0.01%	5429
2023 Q4	$4.6K	Buy	+60	New	+$4.53K	﹤0.01%	6547

Other funds holding ACXP

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

PFS

Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Group One Trading's ACXP Position: Q1 2026 in Review

Group One Trading reduced its Acurx Pharmaceuticals (ACXP) stake by 13% in Q1 2026, selling an estimated $108 and leaving 245 shares worth $909. The position accounts for ﹤0.01% of the portfolio, ranked #7226.

Group One Trading first reported a position in ACXP in Q3 2023 and has held it in 10 quarters since. The position peaked at $33K in Q1 2024. 21 funds tracked by Wall St. Rank hold ACXP as of Q1 2026.

Group One Trading held 245 shares of Acurx Pharmaceuticals worth $909 as of Q1 2026.
Group One Trading sold 38 Acurx Pharmaceuticals shares in Q1 2026, an estimated $108.
Acurx Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7226 holding.
Group One Trading first reported a position in Acurx Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
Group One Trading's Acurx Pharmaceuticals position peaked at $33K in Q1 2024.
21 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.